{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:11:26Z","timestamp":1760141486739,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejso.2018.01.012","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T13:15:58Z","timestamp":1515762958000},"page":"638-643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["High expression of MMP-9 is associated with better prognosis in extrahepatic bile duct cancer patients"],"prefix":"10.1016","volume":"44","author":[{"given":"Younghee","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyubo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Ho","family":"Paik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eui Kyu","family":"Chie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Young","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Whe","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do-Youn","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejso.2018.01.012_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4329\/wjr.v4.i8.345","article-title":"Extrahepatic biliary cancer: New staging classification","volume":"4","author":"Ganeshan","year":"2012","journal-title":"World J Radiol"},{"issue":"5","key":"10.1016\/j.ejso.2018.01.012_bib2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1159\/000360507","article-title":"Update on the management of cholangiocarcinoma","volume":"32","author":"Skipworth","year":"2014","journal-title":"Dig Dis"},{"issue":"2","key":"10.1016\/j.ejso.2018.01.012_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3857\/roj.2014.32.2.63","article-title":"Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapy","volume":"32","author":"Koo","year":"2014","journal-title":"Radiat Oncol J"},{"issue":"11","key":"10.1016\/j.ejso.2018.01.012_bib4","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1245\/s10434-008-9998-7","article-title":"Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone","volume":"15","author":"Borghero","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2018.01.012_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ctrv.2011.05.003","article-title":"Is adjuvant radiotherapy needed after curative resection of extrahepatic biliary tract cancers? A systematic review with a meta-analysis of observational studies","volume":"38","author":"Bonet Beltran","year":"2012","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.ejso.2018.01.012_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/COC.0b013e318209aa29","article-title":"Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience","volume":"35","author":"Kim","year":"2012","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2018.01.012_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3857\/roj.2016.01879","article-title":"Postoperative radiotherapy appeared to improve the disease free survival rate of patients with extrahepatic bile duct cancer at high risk of loco-regional recurrence","volume":"34","author":"Kim","year":"2016","journal-title":"Radiat Oncol J"},{"issue":"Suppl.","key":"10.1016\/j.ejso.2018.01.012_bib8","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/s002800051097","article-title":"Matrix metalloproteinases and metastasis","volume":"43","author":"Kleiner","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"10.1016\/j.ejso.2018.01.012_bib9","first-page":"140","article-title":"Loss of basement membrane components by invasive tumors but not by their benign counterparts","volume":"49","author":"Barsky","year":"1983","journal-title":"Lab Invest"},{"issue":"13 Spec No","key":"10.1016\/j.ejso.2018.01.012_bib10","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0959-8049(00)00156-8","article-title":"Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis","volume":"36","author":"Curran","year":"2000","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2018.01.012_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"10.1016\/j.ejso.2018.01.012_bib12","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S1357-2725(01)00007-3","article-title":"Human endothelial gelatinases and angiogenesis","volume":"33","author":"Nguyen","year":"2001","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"10.1016\/j.ejso.2018.01.012_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.critrevonc.2003.09.001","article-title":"The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia","volume":"50","author":"Klein","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10.1016\/j.ejso.2018.01.012_bib14","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/cncr.10355","article-title":"Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion","volume":"94","author":"Di Nezza","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2018.01.012_bib15","first-page":"1101","article-title":"MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment","volume":"11","author":"Berube","year":"2005","journal-title":"Mol Vis"},{"issue":"5","key":"10.1016\/j.ejso.2018.01.012_bib16","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.humpath.2015.01.014","article-title":"Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis","volume":"46","author":"Desmeules","year":"2015","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.ejso.2018.01.012_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","article-title":"Matrix metalloproteinases and tumor metastasis","volume":"25","author":"Deryugina","year":"2006","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"10.1016\/j.ejso.2018.01.012_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1055-3207(18)30071-1","article-title":"The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis","volume":"10","author":"Stetler-Stevenson","year":"2001","journal-title":"Surg Oncol Clin N Am"},{"issue":"1","key":"10.1016\/j.ejso.2018.01.012_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF03032599","article-title":"The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis","volume":"7","author":"John","year":"2001","journal-title":"Pathol Oncol Res"},{"issue":"3\u20134","key":"10.1016\/j.ejso.2018.01.012_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biochi.2005.01.014","article-title":"Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers","volume":"87","author":"Turpeenniemi-Hujanen","year":"2005","journal-title":"Biochimie"},{"issue":"8","key":"10.1016\/j.ejso.2018.01.012_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1078\/S0344-0338(04)70292-7","article-title":"Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas","volume":"198","author":"Ondruschka","year":"2002","journal-title":"Pathol Res Pract"},{"issue":"5","key":"10.1016\/j.ejso.2018.01.012_bib22","first-page":"1323","article-title":"Patterns of MMP-2 and MMP-9 expression in human cancer cell lines","volume":"21","author":"Roomi","year":"2009","journal-title":"Oncol Rep"},{"issue":"11","key":"10.1016\/j.ejso.2018.01.012_bib23","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1054\/bjoc.2001.1810","article-title":"Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients","volume":"84","author":"Scorilas","year":"2001","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.ejso.2018.01.012_bib24","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/ijc.23337","article-title":"Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer","volume":"122","author":"Wu","year":"2008","journal-title":"Int J Cancer"},{"issue":"22","key":"10.1016\/j.ejso.2018.01.012_bib25","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1158\/1078-0432.CCR-04-1061","article-title":"Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis","volume":"10","author":"Pellikainen","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ejso.2018.01.012_bib26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1158\/1078-0432.CCR-0864-02","article-title":"Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis","volume":"10","author":"Katayama","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.ejso.2018.01.012_bib27","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1158\/1078-0432.CCR-03-0530","article-title":"Expression of Matrix Metalloproteinase-9 in Head and Neck Squamous Cell Carcinoma A Potential Marker for Prognosis","volume":"10","author":"Ruokolainen","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.ejso.2018.01.012_bib28","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/hep.510230608","article-title":"Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors","volume":"23","author":"Terada","year":"1996","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ejso.2018.01.012_bib29","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0039-6060(99)70024-3","article-title":"Expression of matrix metalloproteinase-9 in surgically resected intrahepatic cholangiocarcinoma","volume":"126","author":"Shirabe","year":"1999","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.ejso.2018.01.012_bib30","first-page":"6157","article-title":"High expression of matrix metalloproteinase-9 indicates poor prognosis in human hilar cholangiocarcinoma","volume":"7","author":"Sun","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"10.1016\/j.ejso.2018.01.012_bib31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","article-title":"Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma","volume":"234","author":"Jarnagin","year":"2001","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.ejso.2018.01.012_bib32","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/cncr.20906","article-title":"Impact of ductal resection margin status on long-;term survival in patients undergoing resection for extrahepatic cholangiocarcinoma","volume":"103","author":"Wakai","year":"2005","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2018.01.012_bib33","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1200\/JCO.1997.15.3.947","article-title":"Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors","volume":"15","author":"Klempnauer","year":"1997","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2018.01.012_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jso.20258","article-title":"Predictive value of lymph node and tumor matrix metalloproteinase expression in the analysis of metastatic periampullary tumors","volume":"90","author":"McKenna","year":"2005","journal-title":"J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2018.01.012_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124230","article-title":"Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis","volume":"10","author":"Zhu","year":"2015","journal-title":"PLoS One"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318300428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318300428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:25:32Z","timestamp":1760059532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798318300428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0748798318300428"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2018.01.012","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High expression of MMP-9 is associated with better prognosis in extrahepatic bile duct cancer patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2018.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}